Search
for

    Learn

    5 / 801 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn SCUBE3

      a signaling molecule from dermal papilla cells being actively researched

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Binding affinity of pyrilutamide!

      in Update  169 upvotes 3 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community CB-03-01 / Breezula Personal Results

      in Treatment  16 upvotes 2 months ago
      The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.

      community Wrap it up everyone. CB-03-01 is another failed treatment

      in Treatment  81 upvotes 6 months ago
      CB-03-01 is considered a failed treatment for hair loss, with future hopes pinned on PP-405 and GT-20029, expected by 2030. Alternatives like hair transplants and SMP are discussed, while some users express frustration over the slow progress of treatments like Breezula.

      community Anyone tried CB-03-01?does it work ?

      in Research/Science  2 upvotes 8 months ago
      CB-03-01, also known as Breezula, is being considered as an alternative to DHT blockers for hair loss. Users are discussing its effectiveness, potential regrowth, side effects like scalp irritation, and hormonal impacts.